President Donald Trump unveiled a deal this month with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy.
President Donald Trump speaks as Heidi Overton, deputy director of the White House Domestic Policy Council, from left, David Moore, president of Novo Nordisk Inc., Novo Nordisk President and CEO Mike Doustdar, Eli Lilly CEO David Ricks, Chris Klomp, director of the Centers for Medicare and Medicaid Services, Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, and Health and Human Services Secretary Robert F. Kennedy Jr. listen during an event about drug prices, Nov. 6, in the Oval Office of the White House in Washington.
President Donald Trump speaks as Heidi Overton, deputy director of the White House Domestic Policy Council, from left, David Moore, president of Novo Nordisk Inc., Novo Nordisk President and CEO Mike Doustdar, Eli Lilly CEO David Ricks, Chris Klomp, director of the Centers for Medicare and Medicaid Services, Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, and Health and Human Services Secretary Robert F. Kennedy Jr. listen during an event about drug prices, Nov. 6, in the Oval Office of the White House in Washington.
